Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1971 Dec;68(12):3078–3082. doi: 10.1073/pnas.68.12.3078

Immunologic Enhancement of Allogeneic Tumor Growth with Soluble Histocompatibility-2 Antigens

Lloyd W Law 1, Ettore Appella 1, Peter W Wright 1, Samuel Strober 1,*
PMCID: PMC389594  PMID: 4108871

Abstract

Soluble, partially purified, histocompatibility antigens that were obtained from the membranes of A/J spleen cells have been assayed for their capacity to elicit immunologic enhancement of two tumors of A-strain origin: YAA-C1 and Sarcoma I. Crude membrane material and a partially purified, soluble antigen that were contained in a specific fraction, obtained after chromatography on a Sephadex G-150 column, elicited enhancement; this fraction has been shown to contain immunogenic histocompatibility-2a antigens as well as alloantigenic specificities that were detected serologically. Another soluble fraction did not induce enhancement; this fraction has been shown to contain antigens other than H-2.

Passive enhancement of both tumors was achieved with antisera produced in allogeneic mice that were inoculated with crude membrane material or with a fraction obtained by Sephadex G-150 chromatography. These antisera contained cytotoxic and/or hemagglutinating antibodies. Immunologic enhancement was specific. A readily enhanceable tumor, Py 89, of C57BL origin was not enhanced with anti-H-2a antisera.

These results suggest strongly that all important H-2a transplantation antigenic determinants of spleen cells can be recovered by partial papain digestion and fractionation on a Sephadex G-150 column.

Keywords: tumor-specific transplantation antigen, mice, solubilization, immune tolerance

Full text

PDF
3079

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Graff R. J., Mann D. L., Nathenson S. G. Immunogenic properties of papain-solubilized H-2 alloantigens. Transplantation. 1970 Jul;10(1):59–65. doi: 10.1097/00007890-197007000-00006. [DOI] [PubMed] [Google Scholar]
  2. Graff R. J., Nathenson S. G. Immunogenic properties of papain-solubilized alloantigen. Transplant Proc. 1971 Mar;3(1):249–252. [PubMed] [Google Scholar]
  3. Hellström I., Sjögren H. O. Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro. Exp Cell Res. 1965 Oct;40(1):212–215. doi: 10.1016/0014-4827(65)90320-4. [DOI] [PubMed] [Google Scholar]
  4. KALISS N. Acceptance of tumor homografts by mice injected with antiserum. II. Effect of time of injection. Proc Soc Exp Biol Med. 1956 Mar;91(3):432–437. doi: 10.3181/00379727-91-22285. [DOI] [PubMed] [Google Scholar]
  5. KALISS N., KANDUTSCH A. A. Acceptance of tumor homografts by mice injected with antiserum. I. Activity of serum fractions. Proc Soc Exp Biol Med. 1956 Jan;91(1):118–121. doi: 10.3181/00379727-91-22185. [DOI] [PubMed] [Google Scholar]
  6. Kaliss N. Immunological enhancement. Int Rev Exp Pathol. 1969;8:241–276. [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. MOLLER G. Studies on the mechanism of immunological enhancement of tumor homografts. I. Specificity of immunological enhancement. J Natl Cancer Inst. 1963 Jun;30:1153–1175. [PubMed] [Google Scholar]
  9. Shimada A., Nathenson S. G. Murine histocompatibility-2 (H-2) alloantigens. Purification and some chemical properties of soluble products from H-2b and H-2d genotypes released by papain digestion of membrane fractions. Biochemistry. 1969 Oct;8(10):4048–4062. doi: 10.1021/bi00838a023. [DOI] [PubMed] [Google Scholar]
  10. Snell G. D. Immunologic enhancement. Surg Gynecol Obstet. 1970 Jun;130(6):1109–1119. [PubMed] [Google Scholar]
  11. Strober S., Appella E., Law L. W. Serological and immunogenic activity of soluble mouse transplantation antigens controlled by the H-2 locus. Proc Natl Acad Sci U S A. 1970 Oct;67(2):765–772. doi: 10.1073/pnas.67.2.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. TING R. C., LAW L. W. THE ROLE OF THYMUS IN TRANSPLANTATION RESISTANCE INDUCED BY POLYOMA VIRUS. J Natl Cancer Inst. 1965 Apr;34:521–527. [PubMed] [Google Scholar]
  13. Yamane K., Nathenson S. G. Biochemical similarity of papain-solubilized H-2d alloantigens from tumor cells and from normal cells. Biochemistry. 1970 Nov 24;9(24):4743–4750. doi: 10.1021/bi00826a018. [DOI] [PubMed] [Google Scholar]
  14. Yamane K., Nathenson S. G. Murine histocompatibility-2 (H-2) alloantigens. Purification and some chemical properties of a second class of fragments (class II) solubilized by papain from cell membranes of H-2b and H-2d mice. Biochemistry. 1970 Mar 17;9(6):1336–1341. doi: 10.1021/bi00808a006. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES